Weight-lowering Effects of Glucagon-like Peptide-1 Receptor Agonists and Detection of Breast Cancer Among Obese Women with Diabetes
Conclusions:
In this population-based study, the detection of breast cancer gradually increased with GLP-1 RA weight loss categories, particularly among those achieving>10% weight loss. These results are consistent with the hypothesis that substantial weight loss with GLP-1 RAs may improve detection of breast cancer among obese patients with type 2 diabetes.
Source: Epidemiology - Category: Epidemiology Tags: Pharmacoepidemiology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Epidemiology | Obesity | Study | Weight Loss | Women